TY  - CONF 
AU  - Mariño Callejo, Ana Isabel
PY  - 2014
SN  - 0213-005X
UR  - http://hdl.handle.net/20.500.11940/1231
LA  - eng
TI  - Switching to dual therapy (atazanavir/ritonavir+lamivudine) vs. standard triple therapy (atazanavir/ritonavir+2 nucleos[t]ides) is safe and effective in virologically suppressed patients: 48-week results of a randomized clinical trial (SALT study)
VL  - 32
ER  -